Report cover image

The Worldwide Market for Laboratory-Developed Tests: Services (Labs Performing LDTs) and Equipment (Instruments and Reagents Used in LDTs)

Publisher Kalorama Information
Published Sep 27, 2017
Length 375 Pages
SKU # KLI15485878

Description


The Market for Lab-Developed Test Services and the Market for Instruments and Reagents Sold to Labs

This is a unique report with a unique segmentation to help customers find the right segment for their needs.   Two separate but related markets are discussed in this report:  the market for clinical laboratory services using laboratory developed tests, and the market for products (platforms and consumables) sold to clinical laboratories who uses these products to make LDTs.  Both are large and rapidly growing markets.    As part of the market analysis, the report offers the following data:
• Market for LDT Services in Infectious Disease 
• Market for LDT Services in Cancer Screening 
• Market for LDT Services for Inherited Disorders 
• Investment in LDT Companies, 2016 and 2017
• Status of FDA Regulation of LDT
• Selected Companies/Clinical Laboratories Offering Infectious Disease Test Services Based on LDTs
• Companies/Clinical Laboratories Offering Cancer Screening Test Services Based on LDTs  
• Companies/Clinical Laboratories Offering Genetic Testing for Inherited Disorders 
• Market for Products and Reagents Sold to Labs for Use in LDTs,  
• Market for Products and Reagents Used in LDTs by Type
• Market for Products and Reagents  Used in LDTs by Region.
• M&A Activity: Acquisitions of or by Companies/Laboratories with LDTs 
• Agreements Between Diagnostic Companies with LDTs and Pharmaceutical Companies 
• Direct to Consumer (DTC) Offerings
• Important Conclusions About the Market
• Company Profiles

A Rapidly Moving, Highly Dynamic Market.

Chemistry Tests, Immunoassays  Histology Stains, Flow Cytometry, Karyotyping, ISH, Gene Signatures, Microarrays are among the technologies used in lab develop tests.  This report examines each technology category.  

There are great number of companies in the LDT market.  New LDTs are being developed and introduced, and some segments of this market (especially the market for cancer diagnosis, prognosis, personalized medicine, and monitoring patients) have become very competitive.   Some companies will not survive, but there are also examples of successful companies.  This field has attracted considerable interest from investors and from companies making acquisitions. 

Tracking FDA Actions and Statements and Industry Reaction

There has been considerable discussion in recent years about regulation of this market, and the FDA proposed a draft guidance calling for more FDA oversight of these tests.  However, at this time, the likely outcome of this discussion is not clear.  However, some LDTs available today have already been FDA cleared or approved, and others are likely to be developed into in vitro diagnostic (IVD) tests that a company can ship widely to clinical laboratories.  Early examples of this are discussed in the report.

Comprehensive Research 

There is no other resource that tackles this subject as comprehenisve as Kalorama Information's.  The report is a global report and includes forecast breakouts both in the service and product segments for; The United States, Europe, Asia, Japan, Latin America, China, Rest of World.

Companies Profiled Include:
    
  • 23andMe, Inc.    
  • Adaptive Biotechnologies Corporation    
  • Admera Health    
  • Agendia Nv    
  • Agilenttechnologies Inc.    
  • Altheadx, Inc.    
  • Ambry Genetics Corp.  
  • Applied Proteomics, Inc.  
  • Athena Diagnostics, Inc. (A Quest Diagnostics Business)    
  • BGI 
  • Biodesix, Inc.    
  • Biotheranostics, Inc.    
  • Bruker Corporation    
  • Cancer Genetics, Inc.    
  • Cardiodx, Inc.    
  • Caredx, Inc.    
  • Caris Life Sciences    
  • Castle Biosciences, Inc.    
  • Centogene Ag 
  • Color Genomics, Inc. 
  • Cynvenio Biosystems, Inc. 
  • Epic Sciences, Inc. 
  • Eurofins 
  • Exact Sciences Corporation 
  • Foundation Medicine, Inc. 
  • Genomic Health, Inc. 
  • Genoptix, Inc. Good Start Genetics, Inc. (Acquired By Invitae Corporation) 
  • Grail, Inc. 
  • Guardant Health, Inc. 
  • Helix 
  • Illumina, Inc. 
  • Integrated Diagnostics, Inc. 
  • Invitae Corporation 
  • Laboratory Corporation Of America (Labcorp) 
  • Mdxhealth 
  • Multiplicom Nv (Part Of Agilent Technologies) 
  • Myriad Genetics, Inc. 
  •  Nantomics (Member Of The Nantworks Ecosystem Of Companies) 
  • Natera, Inc. 
  •  Neogenomics, Inc./Neogenomics Laboratories 
  •  Opko Health, Inc./Opko Diagnostics 
  • Pacific Biosciences Of California, Inc. 
  • Perkin Elmer, Inc. 
  •  Qiagen N.V. 
  • Quest Diagnostics 
  •  Roche 
  •  Rosetta Genomics Ltd. 
  •  Sciex 
  • Sera Prognostics, Inc. 
  • Thermo Fisher Scientific, Inc. 
  •  Waters Corporation 

In this report, laboratory developed tests (LDTs) include all clinical tests developed by laboratories for their own use, in contrast to in vitro diagnostic (IVD) kits that are manufactured and sold by diagnostic companies for use by many different clinical labs.  For LDTs, clinical labs do have to purchase instruments and reagents, but these products are not FDA approved/cleared or CE-IVD marked kits (or other kits approved by regulatory authorities of a specific company) that contain everything required to do a test that was developed by the diagnostic company.  The clinical lab uses these reagents to develop and validate the LDT before the test can be used for diagnostic purposes.   The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications.  The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Table of Contents

375 Pages
    • Overview
    • Scope and Methodology
    • Market Overview
    • Future Prospects in the Laboratory Development Test Market
    • Laboratory Develop Tests versus In Vitro Diagnostic Tests
    • Why Do Laboratories Use Laboratory Developed Tests?
    • Laboratory Developed Test Markets Clinical Laboratories Performing Laboratory Developed Tests versus Instrument and Reagent Manufacturers
    • Point-of-View and Methodology
    • What is a Laboratory Developed Test?
    • Other Important Terminology
    • Use of Diagnostic Technologies as Laboratory Developed Tests
    • Infectious Disease
    • Oncology
    • Genetic Testing
    • Pharmacogenomics
    • Mass Spectrometry-Based Tests for Small Molecules
    • Other Laboratory Developed Test Applications
    • Investments/Financings Companies/Clinical Laboratories with LDTs
    • Mergers and Acquisitions
    • Corporate Collaborations
    • Technology
    • Clinical Market Drivers
    • Competition
    • Personalized Medicine and Companion Diagnostics
    • Regulation of Laboratory Developed Tests US and Outside the US
    • Reimbursement
    • Future Prospects
    • Worldwide Laboratory Developed Testing Service Market
    • LDT Services Market by Segment
    • Infectious Disease Laboratory Developed Testing Services Market
    • Oncology Laboratory Developed Testing Services Market
    • Genetic Testing Laboratory Developed Testing Services Market
    • Market for Other Laboratory Developed Tests
    • Uniquness of Market Analysis on LDT Product and Reagents
    • LDT Products and Reagents by Segment (PCR, Mass Spectrometry, NGS. Microarrays and Other)
    • 23andMe, Inc.
    • Adaptive Biotechnologies Corporation
    • Admera Health
    • Agendia NV
    • AgilentTechnologies Inc.
    • AltheaDx, Inc.
    • Ambry Genetics Corp.
    • Applied Proteomics, Inc.
    • Athena Diagnostics, Inc. (A Quest Diagnostics Business)
    • BGI
    • Biodesix, Inc.
    • bioTheranostics, Inc.
    • Bruker Corporation
    • Cancer Genetics, Inc.
    • CardioDx, Inc.
    • CareDx, Inc.
    • Caris Life Sciences
    • Castle Biosciences, Inc.
    • CENTOGENE AG
    • Color Genomics, Inc.
    • Cynvenio Biosystems, Inc.
    • Epic Sciences, Inc.
    • Eurofins
    • Exact Sciences Corporation
    • Foundation Medicine, Inc.
    • Genomic Health, Inc.
    • Genoptix, Inc.
    • Good Start Genetics, Inc. (Acquired by Invitae Corporation)
    • GRAIL, Inc.
    • Guardant Health, Inc.
    • Helix
    • Illumina, Inc.
    • Integrated Diagnostics, Inc.
    • Invitae Corporation
    • Laboratory Corporation of America (LabCorp)
    • MDxHealth
    • Multiplicom NV (Part of Agilent Technologies)
    • Myriad Genetics, Inc.
    • NANTOMICS (Member of the NantWorks ecosystem of companies)
    • Natera, Inc.
    • NeoGenomics, Inc./NeoGenomics Laboratories
    • OPKO Health, Inc./OPKO Diagnostics
    • Pacific Biosciences of California, Inc.
    • PerkinElmer, Inc.
    • QIAGEN N.V.
    • Quest Diagnostics
    • Roche
    • Rosetta Genomics Ltd.
    • SCIEX
    • Sera Prognostics, Inc.
    • Thermo Fisher Scientific, Inc.
    • Waters Corporation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us